New Developing Multiple Sclerosis in a Patient Using Tofacitinib Due to Alopecia Areata

    March 2022 in “ Dermatologic Therapy ”
    Rabia Erçoban, Zeynep Gizem Kaya İslamoğlu
    Studysummary This report presents a case of a patient developing new multiple sclerosis while using tofacitinib for alopecia areata, noting no new comprehensive research findings.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 1

    1. Tofacitinib for the Treatment of Severe Alopecia Areata and Variants: A Study of 90 Patients Journal of The American Academy of Dermatology · 2016

    Related research 1

    1. General Practitioners’ Knowledge and Practices Related to Alopecia Areata in Qassim Region, Saudi Arabia Journal of the Egyptian Public Health Association /Journal of the Egyptian Public Health Association · 2012